`
`
`
`
`;
`
`From:
`
`Sent:
`
`To:
`
`CC:
`
`Fri May 12 2006 16:45:57 EDT
`
`ratna lingamaneni/cambridge/biogen@biogenidec;
`
`bg-12 program team;
`
`yang/cambridge/biogen@biogenidec;
`
`Subject:
`
`Re: BG12 IND - response to clinical hold submitted (5/12/06)
`
`Congratulations team! I know this was a far more significant effort than we thought at first
`glance and we had our share of challenges. I appreciate that we held together as a team and many
`went way above and beyond to get this done quickly. Many thanks for your efforts!
`
`
`____________________________
`
`Sr. Manager, Clinical Development
`Medical Research, Immunology
`Biogen Idec, Inc.
`Cambridge, MA 02142
`
`
`
`
`
`
`
`Ratna Lingamaneni/Cambridge/Biogen
`12-May-2006 04:20 PM
`Message Size: 2.9 KB
`
`To
`
`cc
`
`Subject
`
`
`
`
`
`
`
`
`
`
`
` Minhua Yang/Cambridge/Biogen@BiogenIdec
`
`
`
`
`
`Page 1 of 2
`
`Biogen Exhibit 2343
`Coalition v. Biogen
`IPR2015-01993
`
`
`
`BG12 IND - response to clinical hold submitted (5/12/06)
`
`Dear All,
`
`The BG12 IND - RESPONSE TO CLINICAL HOLD was submitted to the FDA today. Thank
`you to the many people who contributed to this submission.
`
`Please let me know if you have any questions.
`-Ratna
`
`Page 2 of 2